Literature DB >> 27382117

Living in a material world: tumor-treating fields at the top of the charts.

David Schiff1, Deborah Schrag1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27382117      PMCID: PMC4933493          DOI: 10.1093/neuonc/now138

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

Authors:  Scott D Grosse
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2008-04       Impact factor: 2.217

3.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Authors:  Peter J Neumann; Joshua T Cohen; Milton C Weinstein
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

4.  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

Authors:  Roger Stupp; Eric T Wong; Andrew A Kanner; David Steinberg; Herbert Engelhard; Volkmar Heidecke; Eilon D Kirson; Sophie Taillibert; Frank Liebermann; Vladimir Dbalý; Zvi Ram; J Lee Villano; Nikolai Rainov; Uri Weinberg; David Schiff; Lara Kunschner; Jeffrey Raizer; Jerome Honnorat; Andrew Sloan; Mark Malkin; Joseph C Landolfi; Franz Payer; Maximilian Mehdorn; Robert J Weil; Susan C Pannullo; Manfred Westphal; Martin Smrcka; Lawrence Chin; Herwig Kostron; Silvia Hofer; Jeffrey Bruce; Rees Cosgrove; Nina Paleologous; Yoram Palti; Philip H Gutin
Journal:  Eur J Cancer       Date:  2012-05-18       Impact factor: 9.162

Review 5.  The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Authors:  R Garside; M Pitt; R Anderson; G Rogers; M Dyer; S Mealing; M Somerville; A Price; K Stein
Journal:  Health Technol Assess       Date:  2007-11       Impact factor: 4.014

6.  Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

Authors:  Eilon D Kirson; Vladimír Dbalý; Frantisek Tovarys; Josef Vymazal; Jean F Soustiel; Aviran Itzhaki; Daniel Mordechovich; Shirley Steinberg-Shapira; Zoya Gurvich; Rosa Schneiderman; Yoram Wasserman; Marc Salzberg; Bernhard Ryffel; Dorit Goldsher; Erez Dekel; Yoram Palti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

7.  Disruption of cancer cell replication by alternating electric fields.

Authors:  Eilon D Kirson; Zoya Gurvich; Rosa Schneiderman; Erez Dekel; Aviran Itzhaki; Yoram Wasserman; Rachel Schatzberger; Yoram Palti
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States.

Authors:  Andrew Messali; Joel W Hay; Reginald Villacorta
Journal:  Neuro Oncol       Date:  2013-08-09       Impact factor: 12.300

9.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Authors:  Roger Stupp; Sophie Taillibert; Andrew A Kanner; Santosh Kesari; David M Steinberg; Steven A Toms; Lynne P Taylor; Frank Lieberman; Antonio Silvani; Karen L Fink; Gene H Barnett; Jay-Jiguang Zhu; John W Henson; Herbert H Engelhard; Thomas C Chen; David D Tran; Jan Sroubek; Nam D Tran; Andreas F Hottinger; Joseph Landolfi; Rajiv Desai; Manuela Caroli; Yvonne Kew; Jerome Honnorat; Ahmed Idbaih; Eilon D Kirson; Uri Weinberg; Yoram Palti; Monika E Hegi; Zvi Ram
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

10.  Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis.

Authors:  Gabriel Rogers; Ruth Garside; Stuart Mealing; Martin Pitt; Rob Anderson; Matthew Dyer; Ken Stein; Margaret Somerville
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

  10 in total
  2 in total

1.  A systematic review of tumor treating fields therapy for high-grade gliomas.

Authors:  Pavan P Shah; Taija White; Adham M Khalafallah; Carlos G Romo; Carrie Price; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2020-06-23       Impact factor: 4.130

Review 2.  Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis.

Authors:  Ohad Regev; Vladimir Merkin; Deborah T Blumenthal; Israel Melamed; Tehila Kaisman-Elbaz
Journal:  Neurooncol Pract       Date:  2021-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.